DE19929787A1 - Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung - Google Patents

Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung

Info

Publication number
DE19929787A1
DE19929787A1 DE19929787A DE19929787A DE19929787A1 DE 19929787 A1 DE19929787 A1 DE 19929787A1 DE 19929787 A DE19929787 A DE 19929787A DE 19929787 A DE19929787 A DE 19929787A DE 19929787 A1 DE19929787 A1 DE 19929787A1
Authority
DE
Germany
Prior art keywords
alkyl
hydrogen
substituted
different
anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19929787A
Other languages
German (de)
English (en)
Inventor
Juergen Stoltefus
Gabriele Braeunlich
Michael Loegers
Carsten Schmeck
Burkhard Fugmann
Ulrich Nielsch
Martin Bechem
Christian Gerdes
Michael Sperzel
Klemens Lustig
Werner Stuermer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE19929787A priority Critical patent/DE19929787A1/de
Priority to AU55333/00A priority patent/AU5533300A/en
Priority to PCT/EP2000/005570 priority patent/WO2001000601A1/fr
Publication of DE19929787A1 publication Critical patent/DE19929787A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19929787A 1999-06-29 1999-06-29 Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung Withdrawn DE19929787A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE19929787A DE19929787A1 (de) 1999-06-29 1999-06-29 Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung
AU55333/00A AU5533300A (en) 1999-06-29 2000-06-16 Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia
PCT/EP2000/005570 WO2001000601A1 (fr) 1999-06-29 2000-06-16 Nouveaux 4-(2-oxodihydrooxadiazinylphenyl)amides et leur utilisation pour lutter contre les anemies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19929787A DE19929787A1 (de) 1999-06-29 1999-06-29 Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung

Publications (1)

Publication Number Publication Date
DE19929787A1 true DE19929787A1 (de) 2001-01-04

Family

ID=7912944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19929787A Withdrawn DE19929787A1 (de) 1999-06-29 1999-06-29 Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung

Country Status (3)

Country Link
AU (1) AU5533300A (fr)
DE (1) DE19929787A1 (fr)
WO (1) WO2001000601A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072558A1 (fr) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amides d'acide carboxylique antithrombotiques, leur production et leur utilisation comme medicaments
WO2019025562A1 (fr) * 2017-08-04 2019-02-07 Bayer Aktiengesellschaft Dihydrooxadiazinones
US11897867B2 (en) 2017-08-04 2024-02-13 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10010425A1 (de) * 2000-03-03 2001-09-06 Bayer Ag Substituierte 5-Methyldihydropyridazinone und ihre Verwendung
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
EP1852443A1 (fr) 2006-05-05 2007-11-07 Leukocare AG Matrice tridimensionelle biocompatible pour la immobilisation de substances biologiques
EP3558992A4 (fr) * 2016-12-15 2020-12-02 ONO Pharmaceutical Co., Ltd. Activateur de canaux trek (canaux k+ associés à twik)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5962578A (ja) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc オキサジアジン誘導体およびそれを含有する医薬組成物
JPH0676325B2 (ja) * 1992-05-08 1994-09-28 三井東圧化学株式会社 オキサジアジン誘導体を有効成分として含有する抗血栓剤
AU4440596A (en) * 1995-02-10 1996-08-22 Smithkline Beecham Corporation Use of hcp SH2 specific compounds to enhance erythropoiesis
WO1997002024A1 (fr) * 1995-06-30 1997-01-23 Smithkline Beecham Corporation Utilisation de composes se liant specifiquement au domaine stat 5 sh2 pour augmenter l'erythropoiese
CN1211920A (zh) * 1995-12-29 1999-03-24 史密丝克莱恩比彻姆公司 增加红细胞生成的噻吩并[2,3－b]吡唑并[3,4－d]吡啶－3－酮

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072558A1 (fr) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amides d'acide carboxylique antithrombotiques, leur production et leur utilisation comme medicaments
WO2019025562A1 (fr) * 2017-08-04 2019-02-07 Bayer Aktiengesellschaft Dihydrooxadiazinones
US11427553B2 (en) 2017-08-04 2022-08-30 Bayer Aktiengesellschaft Dihydrooxadiazinones
IL272098B1 (en) * 2017-08-04 2023-03-01 Bayer Ag Dihydrooxadiazinones
IL272098B2 (en) * 2017-08-04 2023-07-01 Bayer Ag Dihydrooxadiazinones
US11773070B2 (en) 2017-08-04 2023-10-03 Bayer Aktiengesellschaft Dihydrooxadiazinones
US11897867B2 (en) 2017-08-04 2024-02-13 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer

Also Published As

Publication number Publication date
AU5533300A (en) 2001-01-31
WO2001000601A1 (fr) 2001-01-04

Similar Documents

Publication Publication Date Title
DE19904389A1 (de) Verwendung von substituierten Isoxazolcarbonsäuren und Derivate und neue Stoffe
DE4407047A1 (de) Acetamide
DE19929787A1 (de) Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung
DE10010425A1 (de) Substituierte 5-Methyldihydropyridazinone und ihre Verwendung
EP0723962B1 (fr) Arylalkyl-thiadiazinones
DE10010430A1 (de) Substituierte 5-Ethyl-dihydropyridazinone und ihre Verwendung
DE10010423A1 (de) Substituierte 2,5-Dimethyldihydropyridazinone und ihre Verwendung
DE10010426A1 (de) Verwendung von 6-[4-Aminopheny]-dihydropyridazinonen
WO1997043284A1 (fr) Nouvelles thiazolidinediones, leur procede de preparation et medicaments les contenant
DE19929782A1 (de) 6-Carboxyphenyldihydropyridazinon-Derivate und ihre Verwendung
EP0618201A1 (fr) Thiadiazinones et leur utilisation pour le traitement d'affections cardiovasculaires ou asthmatiques
DE19929781A1 (de) N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
DE10010429A1 (de) Neue 6-[4-Sulfonamidophenyl]-dihydropyridazinone und ihre Verwendung
DE10010422A1 (de) 6-Carboxyphenylpyridazinon-Derivate und ihre Verwendung
DE19929785A1 (de) Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung
WO1996002547A1 (fr) Derives d'acide carboxylique de dioxo-thiopyrano-pyridine et leur utilisation comme medicaments
DE19929783A1 (de) Substituierte 6-[4-(Oxymethyl)-phenyl]-dihydropyridazinone und ihre Verwendung
WO2000045894A2 (fr) Utilisation d'amides d'acides pyrazol-carboxyliques
DE19904406A1 (de) Substituierte Pyrazolcarbonsäuren
DE19904396A1 (de) Substituierte Pyrazolbenzylamin-Derivate
DE19904391A1 (de) Pyrazol-Alkylamide
DE3726425A1 (de) Basisch substituierte saccharine
DE3600594A1 (de) Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
AT389310B (de) Cyclohexandion-derivat und verfahren zu seiner herstellung
DE69523346T2 (de) Substituierte 6-h-1,3,4-thiadiazin-2-amine, deren verwendung als anaesthetisierende cardiovaskulare und hypometabole mittel, und eine sie enthaltende pharmazeutische zubereitung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee